235 related articles for article (PubMed ID: 27210263)
21. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.
Lee V; Chan SY; Choi CW; Kwong D; Lam KO; Tong CC; Sze CK; Ng S; Leung TW; Lee A
Clin Oncol (R Coll Radiol); 2016 Aug; 28(8):e52-60. PubMed ID: 27235379
[TBL] [Abstract][Full Text] [Related]
23. Comparison of radiological and clinical features of temporal lobe necrosis in nasopharyngeal carcinoma patients treated with 2D radiotherapy or intensity-modulated radiotherapy.
Mao YP; Zhou GQ; Liu LZ; Guo R; Sun Y; Li L; Lin AH; Zeng MS; Kang TB; Jia WH; Shao JY; Mai HQ; Ma J
Br J Cancer; 2014 May; 110(11):2633-9. PubMed ID: 24809780
[TBL] [Abstract][Full Text] [Related]
24.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
25. Effects of dosimetric inadequacy on local control and toxicities in the patients with T4 nasopharyngeal carcinoma extending into the intracranial space and treated with intensity-modulated radiotherapy plus chemotherapy.
Xue F; Hu CS; He XY
Chin J Cancer; 2017 Sep; 36(1):76. PubMed ID: 28931426
[TBL] [Abstract][Full Text] [Related]
26. Retrospective dosimetry study of intensity-modulated radiation therapy for nasopharyngeal carcinoma: measurement-guided dose reconstruction and analysis.
Sun WZ; Zhang DD; Peng YL; Chen L; Kang DH; Wang B; Deng XW
Radiat Oncol; 2018 Mar; 13(1):42. PubMed ID: 29544512
[TBL] [Abstract][Full Text] [Related]
27. The risk of secondary cancer in nasopharyngeal carcinoma paediatric patients due to intensity modulated radiotherapy and mega-voltage cone beam computed tomography.
Sherif RS; Attalla EM; Elshemey WM; Madian NG
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):402-409. PubMed ID: 28019086
[TBL] [Abstract][Full Text] [Related]
28. Recommendation for a contouring method and atlas of organs at risk in nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.
Sun Y; Yu XL; Luo W; Lee AW; Wee JT; Lee N; Zhou GQ; Tang LL; Tao CJ; Guo R; Mao YP; Zhang R; Guo Y; Ma J
Radiother Oncol; 2014 Mar; 110(3):390-7. PubMed ID: 24721546
[TBL] [Abstract][Full Text] [Related]
29. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
[TBL] [Abstract][Full Text] [Related]
30. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
[TBL] [Abstract][Full Text] [Related]
31. Radiation-induced nasopharyngeal ulcers after intensity modulated radiotherapy in primary nasopharyngeal carcinoma patients: A dose-volume-outcome analysis.
Li Y; Xu T; Qian W; Lu X; Hu C
Oral Oncol; 2018 Sep; 84():1-6. PubMed ID: 30115466
[TBL] [Abstract][Full Text] [Related]
32. Analysis of late toxicity in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy.
Zheng Y; Han F; Xiao W; Xiang Y; Lu L; Deng X; Cui N; Zhao C
Radiat Oncol; 2015 Jan; 10():17. PubMed ID: 25582731
[TBL] [Abstract][Full Text] [Related]
33. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of a Skin Dose Reduction for Nasopharyngeal Carcinoma Treated With High-Intensity-Modulated Delivery Techniques.
Liao X; Li J; Wang P; Yao X; Zhang Y; Tan T; Orlandini LC
Technol Cancer Res Treat; 2018 Jan; 17():1533033818803582. PubMed ID: 30343642
[TBL] [Abstract][Full Text] [Related]
35. A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patients.
Yu YH; Xia WX; Shi JL; Ma WJ; Li Y; Ye YF; Liang H; Ke LR; Lv X; Yang J; Xiang YQ; Guo X
Chin J Cancer; 2016 Jun; 35(1):59. PubMed ID: 27357728
[TBL] [Abstract][Full Text] [Related]
36. Asymptomatic temporal lobe injury after radiotherapy for nasopharyngeal carcinoma: incidence and determinants.
Leung SF; Kreel L; Tsao SY
Br J Radiol; 1992 Aug; 65(776):710-4. PubMed ID: 1393399
[TBL] [Abstract][Full Text] [Related]
37. Temporal Evolution of Parotid Volume and Parotid Apparent Diffusion Coefficient in Nasopharyngeal Carcinoma Patients Treated by Intensity-Modulated Radiotherapy Investigated by Magnetic Resonance Imaging: A Pilot Study.
Juan CJ; Cheng CC; Chiu SC; Jen YM; Liu YJ; Chiu HC; Kao HW; Wang CW; Chung HW; Huang GS; Hsu HH
PLoS One; 2015; 10(8):e0137073. PubMed ID: 26323091
[TBL] [Abstract][Full Text] [Related]
38. Radiation induced temporal lobe necrosis in nasopharyngeal cancer patients after radical external beam radiotherapy.
Wu VWC; Tam SY
Radiat Oncol; 2020 May; 15(1):112. PubMed ID: 32414378
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a model for temporal lobe necrosis for nasopharyngeal carcinoma patients with intensity modulated radiation therapy.
Wang J; Miao Y; Ou X; Wang X; He X; Shen C; Ying H; Hu W; Hu C
Radiat Oncol; 2019 Mar; 14(1):42. PubMed ID: 30866964
[TBL] [Abstract][Full Text] [Related]
40. Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma.
Chen JL; Huang YS; Kuo SH; Hong RL; Ko JY; Lou PJ; Wang CW
Oncotarget; 2017 Feb; 8(8):14068-14077. PubMed ID: 27764778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]